Wird geladen...
Systemic treatment in advanced soft tissue sarcoma: what is standard, what is new
For metastatic soft tissue sarcoma (STS) patients not eligible for surgery, systemic treatments, including standard chemotherapy and newer biological compounds, still play the most relevant role in the management of the disease. An anthracycline and alkylating agent combination has formed the corner...
Gespeichert in:
| Veröffentlicht in: | BMC Med |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BioMed Central
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5455204/ https://ncbi.nlm.nih.gov/pubmed/28571564 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0872-y |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|